Botanically-derived agent RH324
Term · Oncology and biomedicine · MLC-T-ONC-012081
An orally bioavailable, botanically-derived substance, with potential antineoplastic activity. Though the nature of the plant has yet to be fully elucidated, the botanically-derived agent RH324 contains all the plant's natural constituents, including proteins, amino acids, various fatty acids, carbohydrates, vitamins, minerals, and phytochemicals. Upon oral administration, the botanically-derived agent RH324 may exert its activity by a variety of as of yet not elucidated mechanisms of action.
| Identifier | MLC-T-ONC-012081 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012081",
"term": "Botanically-derived agent RH324",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable, botanically-derived substance, with potential antineoplastic activity. Though the nature of the plant has yet to be fully elucidated, the botanically-derived agent RH324 contains all the plant's natural constituents, including proteins, amino acids, various fatty acids, carbohydrates, vitamins, minerals, and phytochemicals. Upon oral administration, the botanically-derived agent RH324 may exert its activity by a variety of as of yet not elucidated mechanisms of action.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/botanically-derived-agent-rh324/"
}
Record 3,759 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.